Morgan L. Maeder, et al. Therapeutic Correction of an LCA-Causing Splice Defect in the CEP290 Gene by CRISPR/Cas-Mediated Genome Editing. Presented at the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016 in Seattle, WA.

Nov

17

Editas Medicine Announces Clinical Data Demonstrating Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial

Nov

2

Editas Medicine Announces Third Quarter 2022 Results and Business Updates

Oct

26

Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update